Clinical Trial Update: Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults [Phase 2]

View source ↗

Summary

An ongoing Phase 2 trial evaluating dietary omega-7 palmitoleic acid-rich oil on lipoprotein metabolism and satiety in adults with cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Omega-7 palmitoleic acid-rich oil (palmitoleic acid-rich oil (omega-7))

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Disease | Phase 2 | Status: RECRUITING